- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03374631
Stimulating the Social Brain
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Although paranoid ideation is typically associated with severe mental illnesses such as schizophrenia or bipolar disorder, 10-15% of individuals in the general population report experiencing paranoid thoughts on a regular basis. These individuals who are high in sub-clinical paranoia can show impaired work and social functioning as compared to individuals low in sub-clinical paranoia. The wide spread prevalence and negative functional impact of heightened paranoia reinforces the need to develop interventions that may help to reduce problematic patterns of paranoid thinking in both healthy individuals and those with mental illness.
Transcranial Direct Current Stimulation (tDCS) is a form of noninvasive neurostimulation which has been proposed as a therapeutic procedure in numerous psychiatric conditions. TDCS therefore may be a promising therapeutic technique for reducing symptoms of psychosis, and specifically paranoia. This study will compare experiences of paranoid ideation in individuals who are high in sub-clinical paranoia across two conditions: active anodal tDCS and sham tDCS.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Richardson, Texas, United States, 75080
- The Unversity of Texas at Dallas
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- between the ages of 18 ad 35
- previous classification as being high in sub-clinical paranoia
Exclusion Criteria:
- diagnosis of mental illness
- use of psychotropic medication
- Presence or history of medical, cardiac, or neurological disorders that may affect brain function (e.g., cardiac disease, endocrine disorders, renal disease, pulmonary disease, history of seizures or head trauma with unconsciousness for a period of 15 minutes or greater or CNS tumors)
- Presence of sensory limitation including visual (e.g., blindness, glaucoma, vision uncorrectable to 20/40) or hearing (e.g. hearing loss) impairments that interfere with assessment
- Not proficient in English
- Contraindications for tDCS (e.g., pregnancy or implanted devices such as pace maker)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Active anodal tDCS, Then Sham tDCS
Active anodal tDCS followed by behavioral testing; one week later, sham tDCS followed by behavioral testing
|
active anodal tDCS with behavioral tasks and self-report measures to assess paranoid ideation
sham tDCS with behavioral tasks and self-report measures to assess paranoid ideation
|
Sham Comparator: Sham tDCS, then Active anodal tDCS
Sham tDCS followed by behavioral testing; one week later, active anodal tDCS followed by behavioral testing.
|
active anodal tDCS with behavioral tasks and self-report measures to assess paranoid ideation
sham tDCS with behavioral tasks and self-report measures to assess paranoid ideation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in General Paranoid Ideation for Active vs. Sham Simulation
Time Frame: Paranoid ideation will be assessed 30 minutes after completion of the active/sham stimulation
|
Level of paranoid ideation will be assessed with the self-report Paranoia Scale (PS; Fenigstein & Vanable, 1992) both before and after tDCS to assess changes related to tDCS.
The PS is a self-report measure designed to assess sub-clinical paranoid thought.
Scores range from 20-100 with higher scores indicating higher levels of paranoia.
The amount of pre-post change (i.e.
PS score assessed before stimulation minus score after stimulation) is the primary value of interest and will be compared between active and sham stimulation.
Improvements in paranoia will be indicated by positive values.
|
Paranoid ideation will be assessed 30 minutes after completion of the active/sham stimulation
|
Change in Change in Social Paranoia for Active vs. Sham Simulation
Time Frame: Paranoid ideation will be assessed 30 minutes after completion of the active/sham stimulation
|
Level of paranoid ideation will be assessed with the persecution subscale of the State Social Paranoia Scale (SSPS: Freeman et al., 2007) both before and after tDCS to assess changes related to tDCS.
The SSPS is a psychometrically sound 20-item self- report measure assessing current levels of paranoid, positive, and neutral thinking about others.
Ten items comprise the persecution subscale, and scores on this subscale range from 10-50 with higher scores indicating greater paranoia.
The amount of pre-post change (i.e.SSPS score before stimulation minus SSPS score after stimulation) will be compared between active and sham stimulation.
Positive values indicate reductions in paranoia after stimulation.
|
Paranoid ideation will be assessed 30 minutes after completion of the active/sham stimulation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Trustworthiness Task Score for Active vs. Sham Stimulation
Time Frame: assessed 30 minutes after completion of the active/sham stimulation
|
Participants will complete the Trustworthiness Task (Adolphs, Tranel, & Damasio, 1998), which asks individuals to view 42 images of others and rate their level of trustworthiness on a scale from -3 to 3. Scores range from -126 to 126.
Higher scores indicate greater perceptions of trustworthiness.
Mean ratings following each stimulation type (active vs. sham) are calculated.
|
assessed 30 minutes after completion of the active/sham stimulation
|
Penn Emotion Recognition Test for Active vs. Sham Stimulation
Time Frame: assessed 30 minutes after completion of the active/sham stimulation
|
The Emotion Recognition 40 (ER-40; Kohler, Turner, Bilker, Brinsinger, Siegel, Kanes... Gur, 2003) is a standardized, computer administered measure of facial affect recognition ability.
It includes 40 color photographs of faces expressing 4 basic emotions (i.e.
happiness, sadness, anger or fear) and neutral expressions.
Participants view one face at a time and are asked to choose the correct emotion for each face.
Scores range from 0-40 with higher scores indicating better accuracy.
Mean performance following each stimulation type (active vs. sham) are calculated.
|
assessed 30 minutes after completion of the active/sham stimulation
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 17-126
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Adults
-
KU LeuvenCompletedHealthy Older Adults | Ill Older AdultsBelgium
-
Samsung Medical CenterTerminatedHealthy Aging | Healthy AdultsKorea, Republic of
-
King Abdulaziz UniversityUniversity College Dublin; Royal College of Surgeons, IrelandRecruitingHealthy Adults | Healthy NutritionSaudi Arabia
-
Lumos Labs, Inc.Not yet recruitingHealthy AdultsUnited States
-
Shirley Ryan AbilityLabNot yet recruiting
-
National Institute of Allergy and Infectious Diseases...RecruitingHealthy AdultsUnited States
-
Arizona State UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingHealthy AdultsUnited States
-
Marian NeuhouserDuke University; University of Washington; University of Nebraska; United States...Recruiting
-
Mirati Therapeutics Inc.CompletedHealthy AdultsUnited States
-
Ohio State UniversityActive, not recruitingHealthy AdultsUnited States
Clinical Trials on active anodal tDCS
-
University of WaterlooThe Hong Kong Polytechnic UniversityRecruitingMacular DegenerationHong Kong, Canada
-
University of WaterlooThe Hong Kong Polytechnic UniversityCompleted
-
The University of Texas at DallasActive, not recruiting
-
The University of Texas at DallasCompletedSchizophrenia | Schizoaffective DisorderUnited States
-
The University of Texas at DallasCompleted
-
The University of Texas at DallasCompleted
-
Hôpital le VinatierCompletedSchizophrenia | Auditory HallucinationsFrance, Tunisia
-
Stephane ARMANDLa Tour Hospital; School of Health Sciences GenevaRecruitingChronic Low Back PainSwitzerland
-
University of SalernoCompletedProgressive Supranuclear Palsy | Motor and Cognitive SymptomsItaly
-
Riphah International UniversityCompleted